Patients with moderate to high intensity of immunoreactivity of GDF15 in the lymph node metastases did not have any higher risk of recurrence compared with patients with no to low intensity of GDF15 (P=0.08). Here, GDF15 is linked to metastatic malignant neoplasm in the lymph nodes.